LAG525
Showing 1 - 20 of 20
Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)
Completed
- Triple-negative Breast Cancer
- LAG525
- +2 more
-
Chandler, Arizona
- +32 more
Jan 27, 2023
Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)
Completed
- Small Cell Lung Cancer
- +7 more
- PDR001
- LAG525
-
San Francisco, California
- +19 more
May 4, 2022
Migraine, Sleep Disturbance Trial (Feel Bright Light)
Not yet recruiting
- Migraine
- Sleep Disturbance
- Feel Bright Light
- (no location specified)
May 13, 2021
ConforMIS iTotalĀ® (PS) Knee Replacement System
Recruiting
- Osteoarthritis, Knee
- iTotal PS KRS
-
Chapel Hill, North Carolina
- +3 more
Nov 17, 2020
Alcohol Use Disorder Trial in Arnhem (Alcohol Avoidance Training)
Recruiting
- Alcohol Use Disorder
- Alcohol Avoidance Training
-
Arnhem, Gelderland, NetherlandsIrisZorg
Nov 21, 2022
Chronic Illness Trial in Leuven (Mindfulness-Based Intervention)
Unknown status
- Chronic Illness
- Mindfulness-Based Intervention
-
Leuven, Vlaams-Brabant, BelgiumKU Leuven
Aug 17, 2020
HIV Trial in Worldwide (GSK3640254, Placebo matching GSK3640254 Mesylate salt)
Completed
- HIV Infections
- GSK3640254
- Placebo matching GSK3640254 Mesylate salt
-
Bakersfield, California
- +22 more
Jan 27, 2021
Infection, Human Immunodeficiency Virus, HIV Trial in Cambridge (GSK3640254, Placebo)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK3640254
- Placebo
-
Cambridge, United KingdomGSK Investigational Site
May 28, 2021
HIV Trial in Austin (Treatment A, Treatment B, Treatment C)
Completed
- HIV Infections
- Treatment A
- +5 more
-
Austin, TexasGSK Investigational Site
Nov 20, 2019
Dyslipidaemias, Dyslipidemias Trial in United States (10mg atorvastatin, 80mg atorvastatin, GSK1292263 Placebo)
Completed
- Dyslipidaemias
- Dyslipidemias
- 10mg atorvastatin
- +7 more
-
Anniston, Alabama
- +20 more
Jul 5, 2019
Infection, Human Immunodeficiency Virus Trial in United States (GSK1265744 30mg, Placebo, GSK1265744 5mg)
Completed
- Infection, Human Immunodeficiency Virus
- GSK1265744 30mg
- +2 more
-
Fort Lauderdale, Florida
- +3 more
Nov 2, 2017
Sleep, Alertness, Fatigue Trial in Moscow (Bright Light Box)
Completed
- Sleep
- +2 more
- Bright Light Box
-
Moscow, Russian FederationInstitute of Biomedical Problems in Moscow
Apr 28, 2015
Osteoporosis Trial in Worldwide (Bazedoxifene Acetate, Placebo)
Completed
- Osteoporosis
- Bazedoxifene Acetate
- Placebo
-
Birmingham, Alabama
- +375 more
Feb 28, 2013
Mental Retardation, Developmental Delay Disorder Trial in Lawrence (risperidone, clozapine, olanzapine)
Completed
- Mental Retardation
- Developmental Delay Disorder
- risperidone
- +2 more
-
Lawrence, KansasUniversity of Kansas
Jun 23, 2005